Side Effect Management

Patients With Cancer Assess Physical Status Differently vs Caregivers

Patients With Cancer Assess Physical Status Differently vs Caregivers

Caregivers were also more likely to have greater care-related burden when patients reported requiring help with fewer IADLs than did the caregiver.

Telotristat for Diarrhea in Patients With Carcinoid Syndrome

Telotristat for Diarrhea in Patients With Carcinoid Syndrome

Telotristat represents a new treatment option that may decrease diarrhea incidence with a relatively safe side effect profile.

Higher Opioid Prescription Rates Among Survivors of Cancer

Higher Opioid Prescription Rates Among Survivors of Cancer

Researchers enrolled 17,202 individuals, half of whom were cancer survivors and half of whom were healthy controls, to compare opioid prescription rates between the 2 groups.

FDA Expands Approval for Ibrutinib To Include Chronic Graft vs Host Disease

FDA Expands Approval for Ibrutinib To Include Chronic Graft vs Host Disease

The FDA expanded the indications of ibrutinib to include the treatment of adult patients with cGVHD who have failed at least one prior therapy.

Drug-herb and Drug-drug Interactions in Oncology

Drug-herb and Drug-drug Interactions in Oncology

Mixed data highlight the need for researchers to conduct studies to understand the clinical, rather than just theoretical, risks of HDIs and DDIs.

The Adverse Effects of Sarcoma Treatment in Cancer Survivors

The Adverse Effects of Sarcoma Treatment in Cancer Survivors

Adverse events observed in sarcoma survivors highlights the increased need for new, safe treatments, as complications may not be seen until years after the completion of therapy.

Q&A With Dr Shaji Kumar: Ameliorating Bortezomib-induced Peripheral Neuropathy

Q&A With Dr Shaji Kumar: Ameliorating Bortezomib-induced Peripheral Neuropathy

Cancer Therapy Advisor asked Dr Kumar to discuss his team's investigation into a dexamethasone dosing schedule for reducing the rates of peripheral neuropathy.

Tamoxifen- and Placebo-induced Symptoms Yield Similar Adherence Rates to Breast Cancer Prophylactics

Tamoxifen- and Placebo-induced Symptoms Yield Similar Adherence Rates to Breast Cancer Prophylactics

The treatment arms had similar rates of non-adherence, suggesting that patients may misattribute naturally occurring symptoms to preventative therapy.

Ginger Does Not Improve Chemotherapy-associated Nausea

Ginger Does Not Improve Chemotherapy-associated Nausea

Ginger (Zingiber officinale) does not improve chemotherapy-induced nausea and vomiting among patients with cancer.

Korean Red Ginseng Improves Cancer-related Fatigue in Colorectal Cancer

Korean Red Ginseng Improves Cancer-related Fatigue in Colorectal Cancer

Consuming Korean red ginseng was reported to improve cancer-related fatigue among Korean patients with colorectal cancer (CRC) treated with FOLFOX.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters